Advanced Biomed Inc. Common Stock (ADVB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Advanced Biomed Inc. Common Stock (ADVB) has a cash flow conversion efficiency ratio of -0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-6.89K) by net assets ($9.21 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Advanced Biomed Inc. Common Stock for the company's overall valuation and market capitalisation.
Advanced Biomed Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Advanced Biomed Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Advanced Biomed Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Advanced Biomed Inc. Common Stock ranked by their cash flow conversion efficiency. Explore Advanced Biomed Inc. Common Stock earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Vivien Corp
KO:002070
|
-0.021x |
|
SHEARWATER GRP PLC LS-10
F:DTW1
|
N/A |
|
South Malaysia Industries Bhd
KLSE:4375
|
0.000x |
|
Warisan TC Holdings Bhd
KLSE:5016
|
0.007x |
|
CWG Holdings Bhd
KLSE:9423
|
0.098x |
|
Barramundi Group Ltd
OL:BARRA
|
0.044x |
|
Vivesto AB
ST:VIVE
|
-0.039x |
|
Mistral Patrimonio Inmobiliario SOCIMI SA
MC:YMPI
|
0.035x |
Annual Cash Flow Conversion Efficiency for Advanced Biomed Inc. Common Stock (2021–2025)
The table below shows the annual cash flow conversion efficiency of Advanced Biomed Inc. Common Stock from 2021 to 2025. View Advanced Biomed Inc. Common Stock (ADVB) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $3.48 Million | $-181.46K | -0.052x | +95.92% |
| 2024-06-30 | $1.66 Million | $-2.13 Million | -1.278x | +43.68% |
| 2023-06-30 | $1.31 Million | $-2.96 Million | -2.270x | -968.95% |
| 2022-06-30 | $3.49 Million | $-741.45K | -0.212x | +56.26% |
| 2021-06-30 | $976.24K | $-473.98K | -0.486x | -- |
About Advanced Biomed Inc. Common Stock
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagul… Read more